Results

Effect of GSK-3 inhibitors and activator on fruiting body
139 development 140 As shown in Figure 1a , effect of LiCl to C. cinerea fruiting body development was tested.
141 While the control group has already developed into mature fruiting bodies, primordium, 142 initials and hyphal knots were formed on the plates treated with 1.5g/L LiCl respectively. 149 LiCl is not sensitive to heat treatment, and can be autoclaved to sterilize the solution. Any of 150 these delivery methods can be chosen in a large-scale manufacture of the biomaterials.
151 In order to confirm that the inhibition of fruiting body development is caused by GSK-3 152 inhibition, another more specific GSK-3 inhibitor, CHIR99021 trihydrochloride, was tested. 159 LiCl and CHIR99021 trihydrochloride treatments inhibited the fruiting body initiation in a 160 dose-dependent manner (Figure 1a and 1b) . Given that both LiCl and CHIR99021 161 trihydrochloride are specific inhibitors to GSK-3, it can be concluded that the effect of 162 lithium is mediated through the inhibition of GSK-3 activity.
163 To demonstrate that GSK-3 is also important in fruiting body formation in other mushrooms, 164 the effect of LiCl to Pleurotus djamor fruiting body development was tested (Figure 1c) . C. 171 With the positive results that GSK-3 inhibitor can inhibit the fruiting body development, it is 172 hypothesized that GSK-3 activity is associated with the fruiting body development. Then a 173 GSK-3 activator, cisplatin, was tested for its effect on C. cinerea fruiting body development 174 (Figure 1d ). The activator treated group with 1 ml saturated Cisplatin, showed an accelerated 175 development since the formation of hyphal knot, and the mature fruiting body appeared 2 176 days earlier than the control group, while the control group was slower and only developed 177 into young fruiting body. These results showed a positive or promoting effect on C. cinerea 178 fruiting body development by GSK-3 activator, Cisplatin. 
